Related Experiment Video
Updated: Aug 12, 2026
09:58
A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
Recurrent asthma induced by toluene diisocyanate
1Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana.
Thorax
|August 1, 1988
Summary
A worker experienced toluene diisocyanate (TDI) induced asthma, which resolved after leaving his job. Asthma recurred upon returning to work, indicating TDI exposure likely triggered the respiratory symptoms.
Area of Science:
- Occupational Medicine
- Pulmonary Medicine
- Immunology
Background:
- Toluene diisocyanate (TDI) is a chemical used in manufacturing.
- Occupational asthma can develop from exposure to sensitizing agents like TDI.
- Assessing the long-term effects of TDI exposure on respiratory health is crucial.
Observation:
- A worker diagnosed with TDI-induced asthma in 1974 showed no symptoms or bronchial hyperreactivity 11 years after leaving the chemical plant.
- Upon returning to the same workplace, the worker developed asthma within five months.
- Repeat testing revealed bronchial hyperreactivity to methacholine and TDI.
Findings:
- The worker's asthma and bronchial hyperreactivity reappeared with re-exposure to TDI in the workplace.
- This suggests a pattern of TDI sensitivity with reversible hyperresponsiveness.
- The findings support the link between workplace TDI exposure and the recurrence of asthma symptoms.
Implications:
- This case highlights the potential for TDI sensitization to cause recurrent occupational asthma.
- It underscores the importance of identifying and mitigating TDI exposure in the workplace.
- Further research into the mechanisms of TDI-induced asthma and its long-term management is warranted.
Related Concept Videos
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...